HSP90AA1 and COVID-19: In a Syrian hamster model with SARS-CoV-2 GFP/ΔN, the HSP90 inhibitor 17-DMAG significantly reduced COVID-19 lung injury and gene expression of TNF, IL1B and IL6, but clinical deterioration was observed (weight loss exceeding 20% body weight and ruffled fur) [9].